Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. Novartis Pharmaceuticals
2. Cancer Center Support Grant/Core Grant [P30 CA008748]
3. NCI [1K08CA188529-01, KK12CA087723-14, R01CA173636, K99 HL122503-01A1, F30CA18349]
4. NIH National Institute of General Medical Sciences [T32 GM007739]
5. NATIONAL CANCER INSTITUTE [R01CA173636, K12CA087723, K08CA188529, P30CA008748, F30CA183497] Funding Source: NIH RePORTER
6. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122503] Funding Source: NIH RePORTER
7. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER